Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
about
Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and EpigeneticsRole of mitochondrial dysfunction in cancer progressionMolecular markers of paragangliomas/pheochromocytomasA recessive homozygous p.Asp92Gly SDHD mutation causes prenatal cardiomyopathy and a severe mitochondrial complex II deficiency.Case of spontaneous regression of carotid body tumor in a SDHD mutant: a discussion on potential mechanisms based on a review of the literature.No evidence for increased mortality in SDHD variant carriers compared with the general population.Genotype and tumor locus determine expression profile of pseudohypoxic pheochromocytomas and paragangliomasThe genetics and pathology of mitochondrial disease.Familial pheochromocytomas and paragangliomas.Genetics of hereditary head and neck paragangliomas.Novel germline SDHD mutation in a patient with recurrent familial carotid body tumor and concomitant pheochromocytoma.Effects of octreotide therapy in progressive head and neck paragangliomas: case series.No difference in phenotype of the main Dutch SDHD founder mutations.Illness perceptions, risk perception and worry in SDH mutation carriers.Feasibility of a wait-and-scan period as initial management strategy for head and neck paraganglioma.Carotid body tumors are not associated with an increased risk for sleep-disordered breathing.Phenotype of SDHB mutation carriers in the Netherlands.
P2860
Q26796203-2084D465-BE90-4D2D-B4FA-9A90F5B0727CQ28829644-EC4EBEBF-049B-4373-919C-3204649D6472Q33649025-C5D7C664-94EA-4951-9EDE-6309A3C212BBQ35829584-DB32F814-53EF-4012-BB87-D396EB784930Q36406840-8190C01C-21AE-48F1-B22C-1637BC33EDBFQ36695780-AE17E56C-4CCF-4B0A-A98F-491ABEDE73D1Q36730594-CC7A08C7-0FB0-44E5-8DE5-B1A8203CB9BAQ37560946-81A6D828-4246-4BFA-944D-27CBB4718A94Q37568369-9CFCC798-95FA-4B03-84BD-A83D3194E22AQ38126460-11BEA9AA-E33E-4FAE-98E7-22532FEA1192Q38440810-AC0BEE14-9251-4528-AF04-693B24E5CDEAQ43755698-9EDCE588-6F2F-45AB-ABAF-21B444072CB3Q45204437-77BD966C-AD6C-41D2-B97E-EEEBFC8FF162Q47985298-12B29031-0EA6-4C3B-A538-E9B566ACF9F7Q48153618-A77969B5-084F-4E65-9FC9-B07A6FBF5B5AQ48178787-2AF353EF-7F8A-4FB7-8D43-905D1FCE3863Q54198146-5AAEAFF7-4D57-4472-A52C-2DADDDA9B5B4
P2860
Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@en
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@nl
type
label
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@en
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@nl
prefLabel
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@en
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@nl
P2093
P2860
P1476
Mutations in SDHD are the majo ...... d neck paraganglioma patients.
@en
P2093
A G L van der Mey
A H J T Vriends
C J Cornelisse
C M J Tops
E F Hensen
E P M Corssmit
J A Romijn
J C Jansen
J P Bayley
M D Siemers
P2860
P304
P356
10.1111/J.1365-2265.2011.04097.X
P577
2011-11-01T00:00:00Z